Monné Rodríguez, Josep M., Frisk, Anna-Lena, Kreutzer, Robert, Lemarchand, Thomas, Lezmi, Stephane, Saravanan, Chandrassegar, Stierstorfer, Birgit, Thuilliez, Céline, Vezzali, Enrico, Wieczorek, Grazyna, Yun, Seong-Wook and Schaudien, Dirk (2023) European Society of Toxicologic Pathology (Pathology 2.0 Molecular Pathology Special Interest Group): Review of In Situ Hybridization Techniques for Drug Research and Development. Toxicologic pathology. p. 1926233231178282. ISSN 1533-1601

Abstract

In situ hybridization (ISH) is used for the localization of specific nucleic acid sequences in cells or tissues by complementary binding of a nucleotide probe to a specific target nucleic acid sequence. In the last years, the specificity and sensitivity of ISH assays were improved by innovative techniques like synthetic nucleic acids and tandem oligonucleotide probes combined with signal amplification methods like branched DNA, hybridization chain reaction and tyramide signal amplification. These improvements increased the application spectrum for ISH on formalin-fixed paraffin-embedded tissues. ISH is a powerful tool to investigate DNA, mRNA transcripts, regulatory noncoding RNA, and therapeutic oligonucleotides. ISH can be used to obtain spatial information of a cell type, subcellular localization, or expression levels of targets. Since immunohistochemistry and ISH share similar workflows, their combination can address simultaneous transcriptomics and proteomics questions. The goal of this review paper is to revisit the current state of the scientific approaches in ISH and its application in drug research and development.

Item Type:	Article
Date Deposited:	01 Sep 2023 00:45
Last Modified:	01 Sep 2023 00:45
URI:	https://oak.novartis.com/id/eprint/48925